Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,026,436 papers from all fields of science
Search
Sign In
Create Free Account
JTT 705
Known as:
JTT-705
, JTT705
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
dalcetrapib
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Drug Discovery Using Chemical Systems Biology: Identification of the Protein-Ligand Binding Network To Explain the Side Effects of CETP Inhibitors
Li Xie
,
Jerry Li
,
Lei Xie
,
P. Bourne
PLoS Comput. Biol.
2009
Corpus ID: 11260110
Systematic identification of protein-drug interaction networks is crucial to correlate complex modes of drug action to clinical…
Expand
2009
2009
Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia.
F. Hermann
,
F. Enseleit
,
+7 authors
T. Lüscher
Thrombosis Research
2009
Corpus ID: 23703999
Review
2008
Review
2008
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
D. Hausenloy
,
D. Yellon
Postgraduate medical journal
2008
Corpus ID: 743920
The last 20 years have witnessed dramatic reductions in cardiovascular risk using 3-hydroxy-3-methylglutaryl coenzyme A reductase…
Expand
2007
2007
Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma.
H. Okamoto
,
Atsuko Miyai
,
+4 authors
K. Nakajima
Clinica chimica acta; international journal of…
2007
Corpus ID: 45965312
Review
2006
Review
2006
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.
M. Chapman
Pharmacology and Therapeutics
2006
Corpus ID: 23332566
Highly Cited
2005
Highly Cited
2005
Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia.
J. Kuivenhoven
,
G. J. de Grooth
,
+4 authors
J. Kastelein
American Journal of Cardiology
2005
Corpus ID: 2420966
2004
2004
Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbits.
E. Shimoji
,
B. Zhang
,
P. Fan
,
K. Saku
Atherosclerosis
2004
Corpus ID: 20319577
Review
2004
Review
2004
Role of CETP inhibitors in the treatment of dyslipidemia
WA van der Steeg
,
J. Kuivenhoven
,
AH Klerkx
,
S. Boekholdt
,
G. Hovingh
,
J. Kastelein
Current Opinion in Lipidology
2004
Corpus ID: 33636937
Purpose of review This review summarizes novel human data on cholesteryl ester-transfer protein (CETP) and atherosclerosis and…
Expand
Highly Cited
2002
Highly Cited
2002
Cholesteryl ester transfer protein inhibitor (JTT-705) and the development of atherosclerosis in rabbits with severe hypercholesterolaemia.
Zhiping Huang
,
Akihiro Inazu
,
A. Nohara
,
T. Higashikata
,
H. Mabuchi
Clinical science
2002
Corpus ID: 22400248
Cholesteryl ester transfer protein (CETP) is a major determinant of plasma levels of high-density lipoprotein-cholesterol (HDL-C…
Expand
Highly Cited
2000
Highly Cited
2000
bis(2-(Acylamino)phenyl) disulfides, 2-(acylamino)benzenethiols, and S-(2-(acylamino)phenyl) alkanethioates as novel inhibitors of cholesteryl ester transfer protein.
H. Shinkai
,
K. Maeda
,
T. Yamasaki
,
H. Okamoto
,
I. Uchida
Journal of Medicinal Chemistry
2000
Corpus ID: 32923308
A series of bis(2-(acylamino)phenyl) disulfides, 2-(acylamino)benzenethiols, S-(2-(acylamino)phenyl) alkanethioates, and related…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE